Shavkunov Alexander, Panova Neli, Prasai Anesh, Veselenak Ron, Bourne Nigel, Stoilova-McPhie Svetla, Laezza Fernanda
Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas 77555, USA.
Assay Drug Dev Technol. 2012 Apr;10(2):148-60. doi: 10.1089/adt.2011.413. Epub 2012 Feb 24.
Protein-protein interactions are critical molecular determinants of ion channel function and emerging targets for pharmacological interventions. Yet, current methodologies for the rapid detection of ion channel macromolecular complexes are still lacking. In this study we have adapted a split-luciferase complementation assay (LCA) for detecting the assembly of the voltage-gated Na+ (Nav) channel C-tail and the intracellular fibroblast growth factor 14 (FGF14), a functionally relevant component of the Nav channelosome that controls gating and targeting of Nav channels through direct interaction with the channel C-tail. In the LCA, two complementary N-terminus and C-terminus fragments of the firefly luciferase were fused, respectively, to a chimera of the CD4 transmembrane segment and the C-tail of Nav1.6 channel (CD4-Nav1.6-NLuc) or FGF14 (CLuc-FGF14). Co-expression of CLuc-FGF14 and CD4-Nav1.6-NLuc in live cells led to a robust assembly of the FGF14:Nav1.6 C-tail complex, which was attenuated by introducing single-point mutations at the predicted FGF14:Nav channel interface. To evaluate the dynamic regulation of the FGF14:Nav1.6 C-tail complex by signaling pathways, we investigated the effect of kinase inhibitors on the complex formation. Through a platform of counter screenings, we show that the p38/MAPK inhibitor, PD169316, and the IκB kinase inhibitor, BAY 11-7082, reduce the FGF14:Nav1.6 C-tail complementation, highlighting a potential role of the p38MAPK and the IκB/NFκB pathways in controlling neuronal excitability through protein-protein interactions. We envision the methodology presented here as a new valuable tool to allow functional evaluations of protein-channel complexes toward probe development and drug discovery targeting ion channels implicated in human disorders.
蛋白质-蛋白质相互作用是离子通道功能的关键分子决定因素,也是药物干预的新兴靶点。然而,目前仍缺乏快速检测离子通道大分子复合物的方法。在本研究中,我们采用了一种分裂荧光素酶互补分析(LCA)来检测电压门控钠(Nav)通道C末端与细胞内成纤维细胞生长因子14(FGF14)的组装,FGF14是Nav通道体的一个功能相关成分,通过与通道C末端直接相互作用来控制Nav通道的门控和靶向。在LCA中,萤火虫荧光素酶的两个互补的N末端和C末端片段分别与CD4跨膜片段和Nav1.6通道C末端的嵌合体(CD4-Nav1.6-NLuc)或FGF14(CLuc-FGF14)融合。CLuc-FGF14和CD4-Nav1.6-NLuc在活细胞中的共表达导致FGF14:Nav1.6 C末端复合物的强烈组装,通过在预测的FGF14:Nav通道界面引入单点突变,这种组装会减弱。为了评估信号通路对FGF14:Nav1.6 C末端复合物的动态调节,我们研究了激酶抑制剂对复合物形成的影响。通过反向筛选平台,我们发现p38/丝裂原活化蛋白激酶(MAPK)抑制剂PD169316和IκB激酶抑制剂BAY 11-7082可降低FGF14:Nav1.6 C末端的互补作用,突出了p38 MAPK和IκB/核因子κB(NFκB)通路在通过蛋白质-蛋白质相互作用控制神经元兴奋性方面的潜在作用。我们设想这里介绍的方法是一种新的有价值的工具,可用于对蛋白质-通道复合物进行功能评估,以促进针对涉及人类疾病的离子通道的探针开发和药物发现。